Skip to content

Exploring the Effects and Mechanisms of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Myocardial Injury in Patients Undergoing Abdominal Surgery

The Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Enhanced Recovery After Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125789
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative myocardial injury

Interventions

taVNS group:Electrical stimulation parameters (frequency: 25 Hz, pulse width: 200 µs) were applied, starting at 10 mA until participants reported a "tingling sensation" within 20 seconds of initiation
control group:Low-stimulation parameters were used, with a current frequency of 1 Hz and a pulse width of 200 µs. The same procedural steps as in the taVNS group were followed.

Sponsors

Jincheng People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=65 years, or age >=45 years with at least one cardiac risk factor (e.g., diabetes mellitus, hypertension, coronary artery disease, etc.); 2. American Society of Anesthesiologists (ASA) physical status classification >= III; 3. Scheduled for abdominal surgery with an expected operative duration >= 120 minutes; 4. Preoperative New York Heart Association (NYHA) functional class I–II; 5. No contraindications to taVNS.

Exclusion criteria

Exclusion criteria: 1. Acute heart failure with NYHA functional class III–IV; 2. History of arrhythmia, myocardial infarction, or coronary artery bypass grafting; 3. Auricular deformity, infection, or skin damage precluding auricular stimulation; 4. Cognitive impairment interfering with completion of scale assessments; 5. Allergy to materials of the stimulation device.

Design outcomes

Primary

MeasureTime frame
hs-cTnI;Perioperative Neurocognitive Disorders;HRV;Inflammatory factors (C-reactive protein and IL-6).;

Secondary

MeasureTime frame
length of stay (LOS);Perioperative Sleep Quality;nausea and vomiting;Postoperative recovery of gastrointestinal function;Quality of postoperative recovery;the satisfaction of patients;Postoperative pain score;

Countries

China

Contacts

Public ContactLi Luyao; Wang Jinping

Jincheng People's Hospital

994328980@qq.com+86 135 9334 0817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026